The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
about
The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.Ecological networking of cystic fibrosis lung infections.The metabolic footprint of the airway bacterial community in cystic fibrosis.Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.The Microbiome and the Respiratory TractIron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.COMPUTATIONAL APPROACHES TO STUDY MICROBES AND MICROBIOMES.The Microbiome in Cystic Fibrosis.Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory SamplesCystic fibrosis lung environment and Pseudomonas aeruginosa infection.The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patientsLongitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputaThe microbiome and critical illnessCyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental FactorsMetabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease.How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?The airway microbiota in early cystic fibrosis lung disease.A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.Biomarkers for cystic fibrosis drug development.Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions.The lung mycobiome in the next-generation sequencing era.Role of vitamin D on gut microbiota in cystic fibrosis.The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?Episodic oral antibiotic use in CF: Discordance between the electronic medical record and self-reportPseudomonas aeruginosa-Derived Rhamnolipids and Other Detergents Modulate Colony Morphotype and Motility in the Burkholderia cepacia Complex.Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year PeriodMicrobial diversity within the airway microbiome in chronic pediatric lung diseases.Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients.Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New.Gender differences in bronchiectasis: a real issue?Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNAMicrobial Interactions in the Cystic Fibrosis Airway
P2860
Q33644835-9904B1E4-F9C9-4CEA-8F53-A85730C814C0Q33767505-8DB2624D-E5AE-4BB8-912E-A7DDDD59D82DQ33861701-E52BBA07-14EA-48A8-BCE9-63F29CDDA0B2Q35763672-4A9D05C0-8C28-4561-B70B-EFF7A86B17D8Q35829947-3917BCF9-BF60-401A-889D-5895F1D78B7FQ35862783-A1DC948F-5B79-4447-8757-AB822D1751E3Q35896222-C1BCBE06-FD21-4265-98FF-35C9281B9E41Q35917770-61D7540A-9C98-4B56-BC64-D13ED9EE5BB2Q35993825-5690755E-9875-47F0-90D0-08F9212BED85Q36213685-16407B1C-5C5C-4510-8AB7-6FA7F13C5CAEQ36254351-0EEB1E2C-0FEE-4158-8D61-2814AA60CAB2Q36272824-36A39ED4-43AC-4728-B9CE-1B0C6AD069FCQ36304192-135B8149-FAA7-4C3B-B206-F39884C8982FQ36575777-406BD478-95E7-4E7A-AEFC-466F533577FFQ36909659-10ACD2E7-61F0-40B4-8AD5-0B61EC0A6D55Q37191286-7D507706-6931-4520-BBAC-E92BBABF317DQ38635041-5FEF2A2F-43B2-4B32-959A-E0531A89E114Q38641233-47230253-086E-4827-9058-6078689AED75Q38652042-71D83EA6-FD6B-4DD3-A85C-D091C906307EQ38755600-1704A49C-A7E4-4721-8EED-972F75AF8A61Q38843831-489477B4-F700-42EC-BDD0-E637376D0661Q38968543-0C5B3013-2478-4E0A-B55B-0A67B3108C7BQ39000441-30FAF5DC-70C0-4321-B244-05325ACD4EE4Q39328796-DD89A9F8-4299-4D4A-B6D8-4C89732543F3Q39402027-D301FF07-6661-40CF-AC3D-589397387297Q39785915-80DAC102-AF1B-491E-AEA0-4568E19BD008Q40239225-5C124826-D10E-4A6B-BD99-06AF9947B7ADQ41676206-3842DC31-9A80-4802-B3E2-8E05C7037DC6Q46244354-6DC2FDE0-14E7-4A21-A1A3-D96D3769B27EQ46263483-088037AA-B472-4070-B57E-0489607A2EDBQ46311500-86AAFDD3-DC1B-4E8B-AF29-64D09A0858C7Q52858752-3DD54A59-1FAF-4C72-8239-6A067092E2F3Q55299552-8371E361-656D-4A0C-9ADC-AB8AA2D93030Q56395519-679335D8-938C-473F-B553-17E9C76E3AD4Q57174565-FDCB1478-031A-41F7-A138-BE78561C6F53
P2860
The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The daily dynamics of cystic f ...... stability and at exacerbation
@ast
The daily dynamics of cystic f ...... stability and at exacerbation
@en
type
label
The daily dynamics of cystic f ...... stability and at exacerbation
@ast
The daily dynamics of cystic f ...... stability and at exacerbation
@en
prefLabel
The daily dynamics of cystic f ...... stability and at exacerbation
@ast
The daily dynamics of cystic f ...... stability and at exacerbation
@en
P2093
P2860
P1433
P1476
The daily dynamics of cystic f ...... stability and at exacerbation
@en
P2093
Arvind Venkataraman
Jiangchao Zhao
John J LiPuma
Linda M Kalikin
Lisa A Carmody
Richard H Simon
William LeBar
P2860
P2888
P356
10.1186/S40168-015-0074-9
P577
2015-04-01T00:00:00Z
P5875
P6179
1032855640